NCT04015843|Unknown
Loading search results
Sponsor study identifier
observational
1,800
1 country
1
Study Start
August 22, 2019
Actual (reported)Primary Completion
August 30, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
November 30, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This is a multi-center, prospective cohort study that collects only diagnostic and therapeutic data in subjects but does not interfere with treatment.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 30, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 3, 2019
Actual (reported)July 11, 2019
Actual (reported)August 22, 2019
Actual (reported)August 30, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
November 30, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The primary endpoint will be compliance of blood pressure in hypertensive patients after 3 months of treatment in hospitals at different levels.
Blood pressure measurement: Blood pressure in both upper arms will be measured with a sphygmomanometer, with the patient in the sitting position. The mean value of three tests will be used for statistics. When left and right upper arms show different blood pressures, the higher value will be used for statistics.
3 months
Percentage of outpatients with abnormal blood lipid levels in hospitals at different levels
3 months
Achievement rate of blood lipid levels in hypertensive and dyslipidemic patients after 3 months of treatment in hospitals at different levels
3 months
Compliance of patients towards antihypertensive and lipid-lowering treatments in hospitals at different levels
3 months
Factors affecting blood pressure and lipid compliance in different hospitals, such as patient adverse events
3 months
Achievement rate of blood pressure in hypertensive patients under different levels of hospital management after 1 month of treatment
1 months
Initial diagnosis of primary hypertension
Wuhan Asia Heart Hospital
Wuhan, Hubei, China
yong huo, master
Peking University First Hospital
First Submitted
July 3, 2019
First Posted
July 11, 2019
Study Start
August 22, 2019
Actual (reported)Primary Completion
August 30, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Effectiveness of A Hemodynamic-Guided Treatment Strategy to Improve Blood Pressure Control
Hypertension Registry of "Hypertension Prevention and Control Initiative in China"
Contact the study team to confirm eligibility.
Study Completion
November 30, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
November 25, 2019
Record last verified: 2019-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: